Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]
Asclepion Laser Technologies offers different technologies for a multitude of aesthetic and medical treatments. With new products and follow up models of almost legendary systems like the MCL29 Dermablate, RubyStar, […]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. More information: privacy statement and here.
Ok